Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock*
- 1 August 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 32 (8) , 1643-1647
- https://doi.org/10.1097/01.ccm.0000133694.28370.7f
Abstract
Among patients with congestive heart failure, B-type natriuretic peptide measurement is useful to estimate filling pressures and to prognosticate adverse outcome. However, among critically ill intensive care unit patients with shock, the utility of B-type natriuretic peptide to assess cardiac hemodynamics or prognosis has not been explored. Clinical investigation. Hospital. Forty-nine patients with shock and indication for pulmonary artery catheterization. Analysis for B-type natriuretic peptide was performed on blood obtained at the time of catheter placement. Correlations between B-type natriuretic peptide and pulmonary artery occlusion pressure as well as cardiac index were calculated using Spearman analysis. Mortality at the time of study completion was correlated with B-type natriuretic peptide values and Acute Physiology and Chronic Health Evaluation II scores, and logistic regression identified independent predictors of mortality. A wide range of B-type natriuretic peptide concentrations was seen in intensive care unit patients (5000 pg/mL); only eight patients (16%) had normal B-type natriuretic peptide concentrations. Log-transformed B-type natriuretic peptide concentrations did not correlate with interpatient cardiac index or pulmonary artery occlusion pressure (all p = not significant); however, a B-type natriuretic peptide <350 pg/mL had a negative predictive value of 95% for the diagnosis of cardiogenic shock. Median B-type natriuretic peptide concentrations were higher in those who died than those who survived (943 pg/mL vs. 378 pg/mL, p <.001). In multivariable analysis, a B-type natriuretic peptide concentration in the highest log-quartile was the strongest predictor of mortality (odds ratio = 4.50, 95% confidence interval = 1.87-99.0, p <.001). B-type natriuretic peptide concentrations are frequently elevated among critically ill patients in the intensive care unit and cannot be used as a surrogate for pulmonary artery catheterization. B-type natriuretic peptide concentrations in intensive care unit shock may provide powerful information for use in mortality prediction.Keywords
This publication has 31 references indexed in Scilit:
- A Randomized, Controlled Trial of the Use of Pulmonary-Artery Catheters in High-Risk Surgical PatientsNew England Journal of Medicine, 2003
- Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic functionThe American Journal of Cardiology, 2002
- Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic DysfunctionJAMA, 2002
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunctionThe American Journal of Medicine, 2001
- A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot studyJournal of Cardiac Failure, 2001
- Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunctionAmerican Heart Journal, 2001
- Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial InfarctionCirculation, 1996
- Toward an Epidemiology and Natural History of SIRS (Systemic Inflammatory Response Syndrome)JAMA, 1992
- A Community-Wide Assessment of the Use of Pulmonary Artery Catheters in Patients with Acute Myocardial InfarctionChest, 1987